Description
EMPIGET-M Tablets 12.5mg + 1000mg (14’s pack) combine Empagliflozin and Metformin to provide effective management of type 2 diabetes mellitus. Each tablet contains 12.5mg of Empagliflozin, an SGLT2 inhibitor that promotes glucose excretion through the kidneys, and 1000mg of Metformin, which decreases hepatic glucose production and improves insulin sensitivity.
This combination supports improved blood sugar control, aids in weight management, and may offer cardiovascular benefits. The 14-tablet pack provides a convenient supply for ongoing therapy.
Manufactured under strict quality controls, EMPIGET-M Tablets ensure safety, efficacy, and consistent therapeutic outcomes. Patients should take the medication as prescribed and maintain a healthy lifestyle including diet and exercise.
Reviews
There are no reviews yet.